[18F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma

被引：5

作者：

Vergote, Vibeke K. J. ^{[1
]}

Verhoef, Gregor ^{[1
]}

Janssens, Ann ^{[1
]}

Woei-A-Jin, F. J. Sherida H. ^{[2
]}

Laenen, Annouschka ^{[3
]}

Tousseyn, Thomas ^{[4
]}

Dierickx, Daan ^{[1
]}

Deroose, Christophe M. ^{[5
]}

机构：

[1] Univ Hosp Leuven, Hematol, Herestr 49, B-3000 Leuven, Belgium

[2] Univ Hosp Leuven, Gen Med Oncol, Leuven, Belgium

[3] Biostat & Stat Bioinformat Ctr, Leuven, Belgium

[4] Univ Hosp Leuven, Pathol, Leuven, Belgium

[5] Univ Hosp Leuven, Nucl Med, Leuven, Belgium

来源：

LEUKEMIA & LYMPHOMA | 2023年 / 64卷 / 01期

关键词：

Mantle cell lymphoma; F-18]FDG-PET; CT; metabolic tumor volume; lesion dissemination; prognosis; METABOLIC TUMOR VOLUME; STAGE HODGKIN LYMPHOMA; PROGNOSTIC VALUE; RESPONSE ASSESSMENT; INDEX;

D O I：

10.1080/10428194.2022.2131415

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several studies have shown a strong predictive value for pretreatment [F-18]FDG-PET/CT metabolic parameters in different lymphoma subtypes. However, few publications exist concerning the role of metabolic parameters in mantle cell lymphoma (MCL). We retrospectively investigated the prognostic value of baseline metabolic tumor volume (MTV) and lesion dissemination in untreated MCL. We compared it to currently used prognostic factors such as stage, mantle cell lymphoma international prognostic index (MIPI) and KI-67. We report that a higher baseline MTV is a risk factor for worse overall survival (OS), progression-free survival (PFS), and disease-specific survival (DSS) in univariate analysis. In multivariate analysis, MTV was significantly associated with DSS, but not with OS and PFS. We found no correlation between lesion dissemination and outcome. The MIPI score remains the strongest predictor of outcome. These results show that MTV is an important prognostic tool and can improve patient risk stratification at staging of untreated MCL.

引用

页码：161 / 170

页数：10

共 36 条

[11] Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].

Cheson, Bruce D. ;

Fisher, Richard I. ;

Barrington, Sally F. ;

Cavalli, Franco ;

Schwartz, Lawrence H. ;

Zucca, Emanuele ;

Lister, T. Andrew .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+

[12] 18F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome [J].

Cottereau, Anne-Segolene ;

Nioche, Christophe ;

Dirand, Anne-Sophie ;

Clerc, Jerome ;

Morschhauser, Franck ;

Casasnovas, Olivier ;

Meignan, Michel ;

Buvat, Irene .

JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) :40-45

[13] Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial [J].

Cottereau, Anne-Segolene ;

Versari, Annibale ;

Loft, Annika ;

Casasnovas, Olivier ;

Bellei, Monica ;

Ricci, Romain ;

Bardet, Stephane ;

Castagnoli, Antonio ;

Brice, Pauline ;

Raemaekers, John ;

Deau, Benedicte ;

Fortpied, Catherine ;

Raveloarivahy, Tiana ;

Van Zele, Emelie ;

Chartier, Loic ;

Borght, Thierry Vander ;

Federico, Massimo ;

Hutchings, Martin ;

Ricardi, Umberto ;

Andre, Marc ;

Meignan, Michel .

BLOOD, 2018, 131 (13) :1456-1463

[14] Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study [J].

Durmo, Rexhep ;

Donati, Benedetta ;

Rebaud, Louis ;

Cottereau, Anne Segolene ;

Ruffini, Alessia ;

Nizzoli, Maria Elena ;

Ciavarella, Sabino ;

Vegliante, Maria Carmela ;

Nioche, Christophe ;

Meignan, Michel ;

Merli, Francesco ;

Versari, Annibale ;

Ciarrocchi, Alessia ;

Buvat, Irene ;

Luminari, Stefano .

HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) :645-657

[15] TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy [J].

Eskelund, Christian W. ;

Dahl, Christina ;

Hansen, Jakob W. ;

Westman, Maj ;

Kolstad, Arne ;

Pedersen, Lone B. ;

Montano-Almendras, Carmen P. ;

Husby, Simon ;

Freiburghaus, Catja ;

Ek, Sara ;

Pedersen, Anja ;

Niemann, Carsten ;

Raty, Riikka ;

Brown, Peter ;

Geisler, Christian H. ;

Andersen, Mette K. ;

Guldberg, Per ;

Jerkeman, Mats ;

Gronbaek, Kirsten .

BLOOD, 2017, 130 (17) :1903-1910

[16]

Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO

[17]

2-4

[18] A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma [J].

Hoster, Eva ;

Dreyling, Martin ;

Klapper, Wolfram ;

Gisselbrecht, Christian ;

van Hoof, Achiel ;

Kluin-Nelemans, Hanneke C. ;

Pfreundschuh, Michael ;

Reiser, Marcel ;

Metzner, Bernd ;

Einsele, Hermann ;

Peter, Norma ;

Jung, Wolfram ;

Woermann, Bernhard ;

Ludwig, Wolf-Dieter ;

Duehrsen, Ulrich ;

Eimermacher, Hartmut ;

Wandt, Hannes ;

Hasford, Joerg ;

Hiddemann, Wolfgang ;

Unterhalt, Michael .

BLOOD, 2008, 111 (02) :558-565

[19] Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network [J].

Hoster, Eva ;

Rosenwald, Andreas ;

Berger, Francoise ;

Bernd, Heinz-Wolfram ;

Hartmann, Sylvia ;

Loddenkemper, Christoph ;

Barth, Thomas F. E. ;

Brousse, Nicole ;

Pileri, Stefano ;

Rymkiewicz, Grzegorz ;

Kodet, Roman ;

Stilgenbauer, Stephan ;

Forstpointner, Roswitha ;

Thieblemont, Catherine ;

Hallek, Michael ;

Coiffier, Bertrand ;

Vehling-Kaiser, Ursula ;

Bouabdallah, Reda ;

Kanz, Lothar ;

Pfreundschuh, Michael ;

Schmidt, Christian ;

Ribrag, Vincent ;

Hiddemann, Wolfgang ;

Unterhalt, Michael ;

Kluin-Nelemans, Johanna C. ;

Hermine, Olivier ;

Dreyling, Martin H. ;

Klapper, Wolfram .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (12) :1386-+

[20] Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management [J].

Jain, Preetesh ;

Wang, Michael .

AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (06) :710-725

← 1 2 3 4 →